Candida auris was first described in Japan and since then outbreaks of infection and colonization considered serious by C. auris have been reported in different countries. This work aims to show, with updated and relevant information from the literature, the potential for emergence of the yeast C.auris, as well as to present knowledge about the means of drug resistance of this pathogen. This study is an integrative literature review. The emergence of C.auris is characterized by its high capacity for drug resistance, with various resistance mechanisms and preference for hospital environments, especially immunosuppressed patients. The pathogen has limited therapeutic options and can cause several infections, most of which are serious, as they occur in conjunction with other adjacent complications such as COVID-19. C. auris has a high potential to be the protagonist of a new pandemic with a characteristic of multidrug resistance and the capacity for high mortality rates.